Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Walmsley

Showing results (111-120 of 199) with videos related to

Pageof 20
Sort By:
HIV Clinical Trials|May 15, 2015
Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort studyMan Wah Yeung, Jim Young, Erica Moodie, et al.
HIV Clinical Trials|April 19, 2011
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, CanadaNisha Andany, Janet M Raboud, Sharon Walmsley, et al.
The Journal of Infectious Diseases|January 13, 2010
Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trialJamal Suleiman, Barry S Zingman, Ricardo Sobhie Diaz, et al.
AIDS and Behavior|September 30, 2010
Once daily dosing improves adherence to antiretroviral therapyJanet Raboud, Maggie Li, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2017
The Use of Multistate Models to Examine Associations of Stress and Adherence With Transitions Among HIV Care States Observed in a Clinical HIV CohortSandra Blitz, Tony Antoniou, Ann Burchell, et al.
BMC Medical Research Methodology|March 19, 2013
Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort studyJanet Raboud, DeSheng Su, Ann N Burchell, et al.
AIDS (London, England)|April 5, 2019
Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-upNadine Kronfli, Sahir R Bhatnagar, Mark W Hull, et al.
AIDS (London, England)|November 12, 2014
Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trialsFrançois Raffi, Anita Rachlis, Cynthia Brinson, et al.
Viruses|February 28, 2023
Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV)-CTN 314Alice Zhabokritsky, Rosemarie Clarke, Ron Rosenes, et al.
BMC Health Services Research|July 1, 2021
Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trialKinnon R MacKinnon, Ramandip Grewal, Darrell Hs Tan, et al.
Pageof 20

Showing results (111-120 of 199) with videos related to

Sort By:
Pageof 20
HIV Clinical Trials|May 15, 2015
Changes in quality of life, healthcare use, and substance use in HIV/hepatitis C coinfected patients after hepatitis C therapy: a prospective cohort studyMan Wah Yeung, Jim Young, Erica Moodie, et al.
HIV Clinical Trials|April 19, 2011
Ethnicity and gender differences in lipodystrophy of HIV-positive individuals taking antiretroviral therapy in Ontario, CanadaNisha Andany, Janet M Raboud, Sharon Walmsley, et al.
The Journal of Infectious Diseases|January 13, 2010
Vicriviroc in combination therapy with an optimized regimen for treatment-experienced subjects: 48-week results of the VICTOR-E1 phase 2 trialJamal Suleiman, Barry S Zingman, Ricardo Sobhie Diaz, et al.
AIDS and Behavior|September 30, 2010
Once daily dosing improves adherence to antiretroviral therapyJanet Raboud, Maggie Li, Sharon Walmsley, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|July 13, 2017
The Use of Multistate Models to Examine Associations of Stress and Adherence With Transitions Among HIV Care States Observed in a Clinical HIV CohortSandra Blitz, Tony Antoniou, Ann Burchell, et al.
BMC Medical Research Methodology|March 19, 2013
Representativeness of an HIV cohort of the sites from which it is recruiting: results from the Ontario HIV Treatment Network (OHTN) cohort studyJanet Raboud, DeSheng Su, Ann N Burchell, et al.
AIDS (London, England)|April 5, 2019
Trends in cause-specific mortality in HIV-hepatitis C coinfection following hepatitis C treatment scale-upNadine Kronfli, Sahir R Bhatnagar, Mark W Hull, et al.
AIDS (London, England)|November 12, 2014
Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trialsFrançois Raffi, Anita Rachlis, Cynthia Brinson, et al.
Viruses|February 28, 2023
Correlates of Healthy Aging in Geriatric HIV (CHANGE HIV)-CTN 314Alice Zhabokritsky, Rosemarie Clarke, Ron Rosenes, et al.
BMC Health Services Research|July 1, 2021
Patient perspectives on the implementation of routinised syphilis screening with HIV viral load testing: Qualitative process evaluation of the Enhanced Syphilis Screening Among HIV-positive Men trialKinnon R MacKinnon, Ramandip Grewal, Darrell Hs Tan, et al.
Pageof 20